Epiplakin Expression in Colon Cancer
Author Information
Author(s): Fındık Damla Gül, Şahin Erhan, Türelik Özlem, Güneri Gürkan
Primary Institution: Bilecik Şeyh Edebali University
Hypothesis
This study aims to explore changes in epiplakin expression during the carcinogenesis process from colon polyps to carcinomas.
Conclusion
Decreased epiplakin expression is associated with colon malignancy progression, suggesting its role as a potential marker.
Supporting Evidence
- Epiplakin expression was significantly decreased in colon adenocarcinomas and tubulovillous adenomas compared to normal colon tissues.
- A positive correlation was found between epiplakin expression and the Ki67 proliferation index.
- Adenoma groups exhibited higher proliferation indices compared to cancer groups.
Takeaway
The study found that lower levels of a protein called epiplakin in colon tissues might mean a higher chance of cancer, helping doctors understand and diagnose colon cancer better.
Methodology
The study analyzed 60 tissue samples using immunohistochemistry to assess epiplakin and Ki67 expression, with statistical analyses to evaluate correlations.
Limitations
The study did not include high-grade adenomas, which may affect the generalizability of the findings.
Participant Demographics
The mean age of participants was 61.77 years, with 51.7% male and 48.3% female.
Statistical Information
P-Value
P < 0.05
Confidence Interval
95% CI, 3.98–4.24
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website